darolutamide
orion corp,bayer
['pcsm', 'crpc', 'darolutamide', 'prostate']
darolutamide reduces risk of metastatic progression vs placebo in nmcrpc #asco22 #urology #urologist #pcsm #prostatecancer 
Expert clinical analysis. Practice advice. Policy perspectives.